MedTrace Logo

The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot

NCT01480336 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2013-03-19

No results posted yet for this study

Summary

The purpose of this study is to learn if combination therapy with amiodarone and ranolazine (an approved drug for chest pain) can help prevent arrhythmias.

Conditions

Interventions

DRUG

Amiodarone Plus Ranolazine

Ranolazine 500mg by mouth twice daily

DRUG

Amiodarone with Placebo

stabel dose of amiodarone as prescribed by cardiologist

Sponsors & Collaborators

Principal Investigators

  • William Baker, Pharm.D. · University of Connecticut

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01480336 on ClinicalTrials.gov